Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01788475 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
A NA study, sponsored by Lahey Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01788475: Clinical Trial NA study, sponsored by Lahey Clinic.
NCT01788475 is a NA study that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01788475, a NA study, was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Currently medications injected intravitreally in previously vitrectomized eyes have a very short half-life due to enhanced clearance of the drug. The use of the Ozurdex (dexamethasone) implant may allow sustained levels of steroid delivery to patients with diabetic macular edema that have undergone prior vitrectomy. The sustained steroid levels may lead to improved central retinal thickness measurements and improved visual acuity.
Primary Outcome
Measured visual acuity gain in number of letters improved as a result of treatment
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-02-22 |
| Est. Completion | 2014-11-12 |
| Phase | NA |
Why NCT01788475 stopped before completion
NCT01788475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT01788475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01788475 about?
NCT01788475 is a clinical study titled "Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery". Currently medications injected intravitreally in previously vitrectomized eyes have a very short half-life due to enhanced clearance of the drug. The use of the Ozurdex (dexamethasone) implant may allow sustained levels of steroid delivery to patients with diabetic macular edema that have undergone ...
What is the current status of trial NCT01788475?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-02-22. Estimated completion is 2014-11-12.
What interventions are being tested in trial NCT01788475?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT01788475?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01788475's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI